GILD
Gilead Sciences Inc
150.90$
+0.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 22.2% | 29.4% | 23.2% | 22.2% | 20.9% | 20.9% | 23.1% | 21.2% | 20.2% | 20.5% | 20.8% | 20.2% | 20.4% | |
| 77.8% | 70.6% | 76.8% | 77.8% | 79.1% | 79.1% | 76.9% | 78.8% | 79.8% | 79.5% | 79.2% | 79.8% | 79.6% | |
| 20.7% | 19.8% | 22.7% | 19.4% | 18.5% | 21.7% | 20.7% | 21.1% | 17.3% | 20.0% | 19.7% | 22.6% | 19.9% | |
| 18.7% | 10.6% | 9.5% | 8.2% | 5.9% | 13.1% | 7.6% | 7.1% | 6.8% | 8.2% | 7.9% | 24.6% | 12.0% | |
| 40.6% | 48.0% | 141.4% | 39.8% | 67.4% | 46.7% | 43.3% | 43.9% | 37.0% | 41.8% | 42.1% | 213.0% | 84.5% | |
| 37.2% | 22.7% | -64.6% | 38.0% | 11.8% | 32.4% | 33.6% | 34.9% | 42.8% | 37.7% | 38.7% | -133.2% | -4.6% | |
| 3.3% | 3.5% | 3.8% | 3.4% | 3.2% | 3.3% | 3.9% | 3.6% | 3.3% | 3.2% | 3.4% | 3.2% | 3.3% | |
| 32.9% | 23.2% | -67.1% | 29.5% | 12.7% | 28.6% | 24.7% | 34.3% | 46.9% | 26.2% | 37.1% | -131.4% | -6.4% | |
| 2.1% | 3.3% | -4.7% | 6.3% | -3.9% | 5.1% | 5.0% | 6.6% | 7.6% | -1.3% | 8.0% | 3.1% | 4.2% | |
| 30.9% | 20.1% | -62.4% | 23.2% | 16.6% | 23.6% | 19.7% | 27.7% | 39.3% | 27.5% | 29.0% | -134.5% | -10.6% | |
| 45.9% | 36.4% | -53.0% | 42.9% | 25.0% | 41.1% | 39.1% | 47.6% | 59.0% | 38.1% | 50.4% | -128.2% | 3.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.